Anavex Life Sciences Corp
AVXL
NASDAQ
Biotechnology
$3.22
USD
-0.05 (-1.53%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $300.34M
Volume 698.1K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SABS | SAB Biotherapeutics Inc | $343.93M | 25.91 | - | - | |
FATE | Fate Therapeutics Inc | $326.37M | - | -52.6% | - | |
IKT | Inhibikase Therapeutics Inc | $324.80M | - | - | - | |
MYGN | Myriad Genetics Inc | $313.25M | - | -3.2% | - | |
AVXL | Anavex Life Sciences Corp | $311.92M | - | - | - | |
AGEN | Agenus Inc | $311.48M | 4.82 | +24.5% | - | |
IRD | Opus Genetics Inc | $304.50M | - | -12.2% | - | |
SRZN | Surrozen Inc | $294.90M | - | -35.6% | - | |
VNDA | Vanda Pharmaceuticals Inc | $293.20M | - | +8.2% | - | |
IMRX | Immuneering Corp | $293.08M | - | - | - | |
ANIK | Anika Therapeutics Inc | $279.30M | - | -2.5% | - |
Top Peer by Growth
Z Squared Inc (Delaware)
+2149.0% YoY Revenue
Best 1-Year Return
Opus Genetics Inc
+238.2% Return